Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luigi Pannarale
Epidermal Growth Factor-Like Domain Multiple 7 (EGFL7): Expression and Possible Effect on Biliary Epithelium Growth in Cholangiocarcinoma
European Journal of Histochemistry
Medicine
Cell Biology
Histology
Biophysics
Related publications
Epidermal Growth Factor-Like Domain 7 Is a Marker of the Endothelial Lineage and Active Angiogenesis
Genesis
Medicine
Endocrinology
Genetics
Cell Biology
Lysophosphatidylcholine Increases Expression of Heparin-Binding Epidermal Growth Factor Like Growth Factor in Human T Lymphocytes
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer
HPB
Hepatology
Gastroenterology
Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy
Oncology Reports
Medicine
Cancer Research
Oncology
453 Effect of Growth Hormone on Epidermal Growth Factor Excretion
Pediatric Research
Child Health
Pediatrics
Perinatology
Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Suppression of the Biological Activities of the Epidermal Growth Factor (EGF)-like Domain by the Heparin-Binding Domain of Heparin-Binding EGF-like Growth Factor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Clinical Significance of Heparin-Binding Epidermal Growth Factor-Like Growth Factor and a Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer
Clinical Cancer Research
Cancer Research
Oncology
Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors
Tumor Biology
Medicine
Cancer Research